Description
Global Public Health Crisis has enflamed due to the outbreak of Covid-19 which has caused immense loss of life and continue to do so. Globally, countries have continued to face shortage of health products and essential medical technology which are necessary to fight. Countries producing essential health products have either banned export or put restriction or raised prices. In contrast, Covid-19 diagnosis, medicines, vaccines, and other medical technologies are urgently needed in right quantities to prevent and constrain several waves of covid globally. Exponential rise in the demand of health products and insufficient supply or no supply has raised questions about effectiveness of Doha Declaration which was negotiated in 2001 between Developed and Developing Countries to thwart such crisis in future. Among all, global vaccination drive is essential to eliminate covid-19 which has been held hostage by vaccine producing countries. This paper seeks to highlight implementation issues or challenges faced by Developing Countries while implementing TRIPS flexibilities recognised by Doha Declaration for accessing health products. Secondly it also highlights the need for temporary TRIPS waiver to enhance availability of vaccines and essential medical products to fight Covid-19 globally.
